BACKGROUND: Hypertension is a frequent complication of chronic renal failure, but its causes are not fully understood. There is indirect evidence that increased activity of the sympathetic nervous system might contribute to hypertension in patients with end-stage renal disease, but sympathetic-nerve discharge has not been measured directly in patients or animals with chronic renal failure. METHODS: We recorded the rate of postganglionic sympathetic-nerve discharge to the blood vessels in skeletal muscle by means of microelectrodes inserted into the peroneal nerve in 18 patients with native kidneys who were undergoing long-term treatment with hemodialysis (of whom 14 had hypertension), 5 patients receiving hemodialysis who had undergone bilateral nephrectomy (of whom 1 had hypertension), and 11 normal subjects. RESULTS. The mean (+/- SE) rate of sympathetic-nerve discharge was 2.5 times higher in the patients receiving hemodialysis who had not undergone nephrectomy than in the normal subjects (58 +/- 3 vs. 23 +/- 3 bursts per minute, P < 0.01). In contrast, the rate of sympathetic-nerve discharge was similar in the patients receiving hemodialysis who had undergone bilateral nephrectomy (21 +/- 6 bursts per minute) and the normal subjects. The rate of sympathetic-nerve discharge in the patients receiving hemodialysis who had not undergone nephrectomy was also significantly higher (P < 0.01) than that in the patients with bilateral nephrectomy, and it was accompanied in the former group by higher values for vascular resistance in the calf (45 +/- 4 vs. 22 +/- 4 units, P < 0.05) and mean arterial pressure (106 +/- 4 vs. 76 +/- 14 mm Hg, P < 0.05). The rate of sympathetic-nerve discharge was not correlated with either plasma norepinephrine concentrations or plasma renin activity. CONCLUSIONS: Chronic renal failure may be accompanied by reversible sympathetic activation, which appears to be mediated by an afferent signal arising in the failing kidneys.
Source Information
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-9034.
This article has been cited by other articles:
Fung, M. M., Chen, Y., Lipkowitz, M. S., Salem, R. M., Bhatnagar, V., Mahata, M., Nievergelt, C. M., Rao, F., Mahata, S. K., Schork, N. J., Brophy, V. H., O'Connor, D. T., for the AASK Co-Investigators,
(2009). Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis. Nephrol Dial Transplant
24: 3677-3686
[Abstract][Full Text]
Luft, F. C.
(2009). Not so free associations. Nephrol Dial Transplant
24: 3576-3577
[Full Text]
Mimura, I., Kawarazaki, H., Momose, T., Shibagaki, Y., Fujita, T.
(2009). Improvement of cardiac function after kidney transplantation with dilated cardiomyopathy and long dialysis vintage. NDT Plus
2: 479-481
[Abstract][Full Text]
Schlaich, M. P., Sobotka, P. A., Krum, H., Whitbourn, R., Walton, A., Esler, M. D.
(2009). Renal Denervation as a Therapeutic Approach for Hypertension: Novel Implications for an Old Concept. Hypertension
54: 1195-1201
[Full Text]
Wang, A. Y.-M., Sea, M. M.-M., Tang, N., Lam, C. W.-k., Chan, I. H.-S., Lui, S.-F., Sanderson, J. E, Woo, J.
(2009). Energy intake and expenditure profile in chronic peritoneal dialysis patients complicated with circulatory congestion. Am. J. Clin. Nutr.
90: 1179-1184
[Abstract][Full Text]
Grassi, G.
(2009). Assessment of Sympathetic Cardiovascular Drive in Human Hypertension: Achievements and Perspectives. Hypertension
54: 690-697
[Abstract][Full Text]
Kesoi, I., Sagi, B., Vas, T., Kovacs, T., Wittmann, I., Nagy, J.
(2009). Heart rate recovery after exercise is associated with renal function in patients with a homogenous chronic renal disease. Nephrol Dial Transplant
0: gfp504v1-gfp504
[Abstract][Full Text]
Chung, A. W.Y., Yang, H.H. C., Kim, J. M., Sigrist, M. K., Chum, E., Gourlay, W. A., Levin, A.
(2009). Upregulation of Matrix Metalloproteinase-2 in the Arterial Vasculature Contributes to Stiffening and Vasomotor Dysfunction in Patients With Chronic Kidney Disease. Circulation
120: 792-801
[Abstract][Full Text]
Schlaich, M. P., Sobotka, P. A., Krum, H., Lambert, E., Esler, M. D.
(2009). Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension. NEJM
361: 932-934
[Full Text]
de Bie, M. K., van Dam, B., Gaasbeek, A., van Buren, M., van Erven, L., Bax, J. J., Schalij, M. J., Rabelink, T. J., Jukema, J. W.
(2009). The current status of interventions aiming at reducing sudden cardiac death in dialysis patients. Eur Heart J
30: 1559-1564
[Abstract][Full Text]
Chen, Y., Mahata, M., Rao, F., Khandrika, S., Courel, M., Fung, M. M., Zhang, K., Stridsberg, M., Ziegler, M. G., Hamilton, B. A., Lipkowitz, M. S., Taupenot, L., Nievergelt, C., Mahata, S. K., O'Connor, D. T.
(2009). Chromogranin A Regulates Renal Function by Triggering Weibel-Palade Body Exocytosis. J. Am. Soc. Nephrol.
20: 1623-1632
[Abstract][Full Text]
Rubinger, D., Backenroth, R., Sapoznikov, D.
(2009). Restoration of baroreflex function in patients with end-stage renal disease after renal transplantation. Nephrol Dial Transplant
24: 1305-1313
[Abstract][Full Text]
Kalaitzidis, R., Bakris, G.
(2009). Should nephrologists use beta-blockers? A perspective. Nephrol Dial Transplant
24: 701-702
[Full Text]
Agarwal, R., Alborzi, P., Satyan, S., Light, R. P.
(2009). Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP): A Randomized, Controlled Trial. Hypertension
53: 500-507
[Abstract][Full Text]
Lutaif, N. A., Rocha, E. M., A.Veloso, L., Bento, L. M., Gontijo, J. A. R.
(2008). Renal contribution to thermolability in rats: role of renal nerves. Nephrol Dial Transplant
23: 3798-3805
[Abstract][Full Text]
Park, J., Campese, V. M., Nobakht, N., Middlekauff, H. R.
(2008). Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease. J. Appl. Physiol.
105: 1873-1876
[Abstract][Full Text]
Chan, C. T.
(2008). Heart rate variability in patients with end-stage renal disease: an emerging predictive tool for sudden cardiac death?. Nephrol Dial Transplant
23: 3061-3062
[Full Text]
Schefer, T., Wolber, T., Binggeli, C., Holzmeister, J., Brunckhorst, C., Duru, F.
(2008). Long-term predictors of mortality in ICD patients with non-ischaemic cardiac disease: impact of renal function. Europace
10: 1052-1059
[Abstract][Full Text]
Ritz, E., Wanner, C.
(2008). The Challenge of Sudden Death in Dialysis Patients. CJASN
3: 920-929
[Full Text]
Li, G., Xu, J., Wang, P., Velazquez, H., Li, Y., Wu, Y., Desir, G. V.
(2008). Catecholamines Regulate the Activity, Secretion, and Synthesis of Renalase. Circulation
117: 1277-1282
[Abstract][Full Text]
Agarwal, R., Bunaye, Z., Bekele, D. M.
(2008). Prognostic Significance of Between-Arm Blood Pressure Differences. Hypertension
51: 657-662
[Abstract][Full Text]
Haddy, F. J., Meyer, T. W., Hostetter, T. H.
(2008). Uremia. NEJM
358: 95-95
[Full Text]
Lundby, C., Boushel, R., Robach, P., Moller, K., Saltin, B., Calbet, J. A. L.
(2008). During hypoxic exercise some vasoconstriction is needed to match O2 delivery with O2 demand at the microcirculatory level. J. Physiol.
586: 123-130
[Abstract][Full Text]
Peterson, G. E., de Backer, T., Gabriel, A., Ilic, V., Vagaonescu, T., Appel, L. J., Contreras, G., Kendrick, C., Rostand, S., Phillips, R. A., for the African American Study of Kidney Disease I,
(2007). Prevalence and Correlates of Left Ventricular Hypertrophy in the African American Study of Kidney Disease Cohort Study. Hypertension
50: 1033-1039
[Abstract][Full Text]
Chan, C. T., Notarius, C. F., Merlocco, A. C., Floras, J. S.
(2007). Improvement in exercise duration and capacity after conversion to nocturnal home haemodialysis. Nephrol Dial Transplant
22: 3285-3291
[Abstract][Full Text]
Kobori, H., Nangaku, M., Navar, L. G., Nishiyama, A.
(2007). The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease. Pharmacol. Rev.
59: 251-287
[Abstract][Full Text]
Schiffrin, E. L., Lipman, M. L., Mann, J. F.E.
(2007). Chronic Kidney Disease: Effects on the Cardiovascular System. Circulation
116: 85-97
[Abstract][Full Text]
Blankestijn, P. J.
(2007). SYMPATHETIC HYPERACTIVITY--A HIDDEN ENEMY IN CHRONIC KIDNEY DISEASE PATIENTS. pdi
27: S293-S297
[Abstract][Full Text]
Neumann, J., Ligtenberg, G., Klein, I. H.T., Boer, P., Oey, P. L., Koomans, H. A., Blankestijn, P. J.
(2007). Response to Sympathetic Hyperactivity in Hypertensive Chronic Kidney Disease Patients Is Reduced During Standard Treatment. Hypertension
49: e28-e28
[Full Text]
Neumann, J., Ligtenberg, G., Klein, I. H.T., Boer, P., Oey, P. L., Koomans, H. A., Blankestijn, P. J.
(2007). Sympathetic Hyperactivity in Hypertensive Chronic Kidney Disease Patients Is Reduced During Standard Treatment. Hypertension
49: 506-510
[Abstract][Full Text]
Jie, K. E., Verhaar, M. C., Cramer, M.-J. M., van der Putten, K., Gaillard, C. A. J. M., Doevendans, P. A., Koomans, H. A., Joles, J. A., Braam, B.
(2006). Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors. Am. J. Physiol. Renal Physiol.
291: F932-F944
[Abstract][Full Text]
Esler, M., Straznicky, N., Eikelis, N., Masuo, K., Lambert, G., Lambert, E.
(2006). Mechanisms of Sympathetic Activation in Obesity-Related Hypertension. Hypertension
48: 787-796
[Full Text]
Petersson, M., Friberg, P., Lambert, G., Rundqvist, B.
(2005). Decreased renal sympathetic activity in response to cardiac unloading with nitroglycerin in patients with heart failure. Eur J Heart Fail
7: 1003-1010
[Abstract][Full Text]
J, X., G, L., P, W., H, V., X, Y., Y, L., Y, W., A, P., S, C., GV, D., H, I., MH, O., K, W., K, B.-J., LH, L., CE, M., B, D., RB, D., U, d. F., F, F., S, J., SE, K., O, L.-P., Nieminen, , P, O., S, O., Y, W., H, X., P, H., Z, L., D, H., P, H., N, M., RJ, F., JC, J.
(2005). Kidney and Blood Pressure--The Story Unfolds: Renalase Is a Novel, Soluble Monoamine Oxidase That Regulates Cardiac Function and Blood Pressure. J Clin Invest. J. Am. Soc. Nephrol.
16: 2521-2527
[Full Text]
Klein, K., Daschner, M., Vogel, M., Oh, J., Feuerstein, T. J., Schaefer, F.
(2005). Impaired Autofeedback Regulation of Hypothalamic Norepinephrine Release in Experimental Uremia. J. Am. Soc. Nephrol.
16: 2081-2087
[Abstract][Full Text]
Petersson, M., Friberg, P., Eisenhofer, G., Lambert, G., Rundqvist, B.
(2005). Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J
26: 906-913
[Abstract][Full Text]
Wuhl, E., Hadtstein, C., Mehls, O., Schaefer, F., the ESCAPE Trial Group,
(2005). Ultradian but not Circadian Blood Pressure Rhythms Correlate with Renal Dysfunction in Children with Chronic Renal Failure. J. Am. Soc. Nephrol.
16: 746-754
[Abstract][Full Text]
Bongartz, L. G., Cramer, M. J., Doevendans, P. A., Joles, J. A., Braam, B.
(2005). The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J
26: 11-17
[Abstract][Full Text]
Deshmukh, S., Phillips, B. G., O'Dorisio, T., Flanigan, M. J., Lim, V. S.
(2005). Hormonal responses to fasting and refeeding in chronic renal failure patients. Am. J. Physiol. Endocrinol. Metab.
288: E47-E55
[Abstract][Full Text]
Stewart, J., Kohen, A., Brouder, D., Rahim, F., Adler, S., Garrick, R., Goligorsky, M. S.
(2004). Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. Am. J. Physiol. Heart Circ. Physiol.
287: H2687-H2696
[Abstract][Full Text]
Mustata, S., Chan, C., Lai, V., Miller, J. A.
(2004). Impact of an Exercise Program on Arterial Stiffness and Insulin Resistance in Hemodialysis Patients. J. Am. Soc. Nephrol.
15: 2713-2718
[Abstract][Full Text]
Kurata, C., Uehara, A., Ishikawa, A.
(2004). Improvement of Cardiac Sympathetic Innervation by Renal Transplantation. JNM
45: 1114-1120
[Abstract][Full Text]
Blankestijn, P. J.
(2004). Sympathetic hyperactivity in chronic kidney disease. Nephrol Dial Transplant
19: 1354-1357
[Full Text]
Doulton, T. W., MacGregor, G. A
(2004). Review: Blood pressure in haemodialysis patients: The importance of the relationship between the renin-angiotensin-aldosterone system, salt intake and extracellular volume. Journal of Renin-Angiotensin-Aldosterone System
5: 14-22
[Abstract]
Ritz, E., McClellan, W. M.
(2004). Overview: Increased Cardiovascular Risk in Patients with Minor Renal Dysfunction: An Emerging Issue with Far-Reaching Consequences. J. Am. Soc. Nephrol.
15: 513-516
[Abstract][Full Text]
Koomans, H. A., Blankestijn, P. J., Joles, J. A.
(2004). Sympathetic Hyperactivity in Chronic Renal Failure: A Wake-up Call. J. Am. Soc. Nephrol.
15: 524-537
[Abstract][Full Text]
Mallamaci, F., Tripepi, G., Maas, R., Malatino, L., Boger, R., Zoccali, C.
(2004). Analysis of the Relationship between Norepinephrine and Asymmetric Dimethyl Arginine Levels among Patients with End-Stage Renal Disease. J. Am. Soc. Nephrol.
15: 435-441
[Abstract][Full Text]
Klein, I. H.H.T., Ligtenberg, G., Neumann, J., Oey, P. L., Koomans, H. A., Blankestijn, P. J.
(2003). Sympathetic Nerve Activity Is Inappropriately Increased in Chronic Renal Disease. J. Am. Soc. Nephrol.
14: 3239-3244
[Abstract][Full Text]
Oparil, S., Zaman, M. A., Calhoun, D. A.
(2003). Pathogenesis of Hypertension. ANN INTERN MED
139: 761-776
[Full Text]
Chan, C. T., Harvey, P. J., Picton, P., Pierratos, A., Miller, J. A., Floras, J. S.
(2003). Short-Term Blood Pressure, Noradrenergic, and Vascular Effects of Nocturnal Home Hemodialysis. Hypertension
42: 925-931
[Abstract][Full Text]
Cice, G., Ferrara, L., D'Andrea, A., D'Isa, S., Di Benedetto, A., Cittadini, A., Russo, P. E., Golino, P., Calabro, R.
(2003). Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: A prospective, placebo-controlled trial. J Am Coll Cardiol
41: 1438-1444
[Abstract][Full Text]
Yang, L. E., Zhong, H., Leong, P. K. K., Perianayagam, A., Campese, V. M., McDonough, A. A.
(2003). Chronic renal injury-induced hypertension alters renal NHE3 distribution and abundance. Am. J. Physiol. Renal Physiol.
284: F1056-F1065
[Abstract][Full Text]
Mitsnefes, M. M., Kimball, T. R., Witt, S. A., Glascock, B. J., Khoury, P. R., Daniels, S. R.
(2003). Left Ventricular Mass and Systolic Performance in Pediatric Patients With Chronic Renal Failure. Circulation
107: 864-868
[Abstract][Full Text]
Klein, I. H.H.T., Ligtenberg, G., Oey, P. L., Koomans, H. A., Blankestijn, P. J.
(2003). Enalapril and Losartan Reduce Sympathetic Hyperactivity in Patients with Chronic Renal Failure. J. Am. Soc. Nephrol.
14: 425-430
[Abstract][Full Text]
Hausberg, M., Kosch, M., Harmelink, P., Barenbrock, M., Hohage, H., Kisters, K., Dietl, K. H., Rahn, K. H.
(2002). Sympathetic Nerve Activity in End-Stage Renal Disease. Circulation
106: 1974-1979
[Abstract][Full Text]
Zoccali, C., Mallamaci, F., Tripepi, G., Parlongo, S., Cutrupi, S., Benedetto, F. A., Cataliotti, A., Malatino, L. S.
(2002). Norepinephrine and Concentric Hypertrophy in Patients With End-Stage Renal Disease. Hypertension
40: 41-46
[Abstract][Full Text]
Ye, S., Zhong, H., Duong, V. N., Campese, V. M.
(2002). Losartan Reduces Central and Peripheral Sympathetic Nerve Activity in a Rat Model of Neurogenic Hypertension. Hypertension
39: 1101-1106
[Abstract][Full Text]
Johnson, R. J., Herrera-Acosta, J., Schreiner, G. F., Rodriguez-Iturbe, B.
(2002). Subtle Acquired Renal Injury as a Mechanism of Salt-Sensitive Hypertension. NEJM
346: 913-923
[Full Text]
Zoccali, C., Mallamaci, F., Parlongo, S., Cutrupi, S., Benedetto, F. A., Tripepi, G., Bonanno, G., Rapisarda, F., Fatuzzo, P., Seminara, G., Cataliotti, A., Stancanelli, B., Malatino, L. S.
(2002). Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease. Circulation
105: 1354-1359
[Abstract][Full Text]
Leineweber, K., Heinroth-Hoffmann, I., Ponicke, K., Abraham, G., Osten, B., Brodde, O.-E.
(2002). Cardiac {beta}-Adrenoceptor Desensitization Due to Increased {beta}-Adrenoceptor Kinase Activity in Chronic Uremia. J. Am. Soc. Nephrol.
13: 117-124
[Abstract][Full Text]
Tycho Vuurmans, J. L., Boer, W. H., Bos, W.-J. W., Blankestijn, P. J., Koomans, H. A.
(2002). Contribution of Volume Overload and Angiotensin II to the Increased Pulse Wave Velocity of Hemodialysis Patients. J. Am. Soc. Nephrol.
13: 177-183
[Abstract][Full Text]
KLEIN, I. H. H. T., LIGTENBERG, G., OEY, P. L., KOOMANS, H. A., BLANKESTIJN, P. J.
(2001). Sympathetic Activity Is Increased in Polycystic Kidney Disease and Is Associated with Hypertension. J. Am. Soc. Nephrol.
12: 2427-2433
[Abstract][Full Text]
De Wardener, H. E.
(2001). The Hypothalamus and Hypertension. Physiol. Rev.
81: 1599-1658
[Abstract][Full Text]
STROJEK, K., GRZESZCZAK, W., GÓRSKA, J., LESCHINGER, M. I., RITZ, E.
(2001). Lowering of Microalbuminuria in Diabetic Patients by a Sympathicoplegic Agent: Novel Approach to Prevent Progression of Diabetic Nephropathy?. J. Am. Soc. Nephrol.
12: 602-605
[Abstract][Full Text]
Cice, G., Ferrara, L., Di Benedetto, A., Russo, P. E., Marinelli, G., Pavese, F., Iacono, A.
(2001). Dilated cardiomyopathy in dialysis patients--beneficial effects of carvedilol: a double-blind, placebo-controlled trial. J Am Coll Cardiol
37: 407-411
[Abstract][Full Text]
Ye, S., Mozayeni, P., Gamburd, M., Zhong, H., Campese, V. M.
(2000). Interleukin-1beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure. Am. J. Physiol. Heart Circ. Physiol.
279: H2786-H2796
[Abstract][Full Text]
Rump, L. C., Amann, K., Orth, S., Ritz, E.
(2000). Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia?. Nephrol Dial Transplant
15: 1735-1738
[Full Text]
DiBona, G. F.
(2000). Neural control of the kidney: functionally specific renal sympathetic nerve fibers. Am. J. Physiol. Regul. Integr. Comp. Physiol.
279: R1517-R1524
[Abstract][Full Text]
AMANN, K., RUMP, L. C., SIMONAVICIENE, A., OBERHAUSER, V., WESSELS, S., ORTH, S. R., GROSS, M.-L., KOCH, A., BIELENBERG, G. W., VAN KATS, J. P., EHMKE, H., MALL, G., RITZ, E.
(2000). Effects of Low Dose Sympathetic Inhibition on Glomerulosclerosis and Albuminuria in Subtotally Nephrectomized Rats. J. Am. Soc. Nephrol.
11: 1469-1478
[Abstract][Full Text]
Blankestijn, P. J., Ligtenberg, G., Klein, I. H. H. T., Koomans, H. A.
(2000). Sympathetic overactivity in renal failure controlled by ACE inhibition: clinical significance. Nephrol Dial Transplant
15: 755-758
[Full Text]
Campese, V. M, Shaohua Ye, , Truong, R. H, Gamburd, M.
(2000). Losartan reduces sympathetic nerve outflow from the brain of rats with chronic renal failure. Journal of Renin-Angiotensin-Aldosterone System
1: 202-208
[Abstract]
Shaldon, S., Scribner, B. H.
(2000). Can antihypertensive medications control BP in haemodialysis patients. Nephrol Dial Transplant
15: 736-736
[Full Text]
Tozawa, M., Iseki, K., Yoshi, S., Fukiyama, K.
(1999). Blood pressure variability as an adverse prognostic risk factor in end-stage renal disease. Nephrol Dial Transplant
14: 1976-1981
[Abstract][Full Text]
Johansson, M., Elam, M., Rundqvist, B., Eisenhofer, G., Herlitz, H., Lambert, G., Friberg, P.
(1999). Increased Sympathetic Nerve Activity in Renovascular Hypertension. Circulation
99: 2537-2542
[Abstract][Full Text]
Ligtenberg, G., Blankestijn, P. J., Oey, P. L., Klein, I. H.H., Dijkhorst-Oei, L.-T., Boomsma, F., Wieneke, G. H., van Huffelen, A. C., Koomans, H. A.
(1999). Reduction of Sympathetic Hyperactivity by Enalapril in Patients with Chronic Renal Failure. NEJM
340: 1321-1328
[Abstract][Full Text]
Thuraisingham, R., Raine, A.
(1999). Maintenance of normal agonist-induced endothelium-dependent relaxation in uraemic and hypertensive resistance vessels. Nephrol Dial Transplant
14: 70-75
[Abstract]
Wenzel, R. R., Spieker, L., Qui, S., Shaw, S., Luscher, T. F., Noll, G.
(1998). I1-Imidazoline Agonist Moxonidine Decreases Sympathetic Nerve Activity and Blood Pressure in Hypertensives. Hypertension
32: 1022-1027
[Abstract][Full Text]
Rahman, M., Smith, M. C.
(1998). Chronic Renal Insufficiency: A Diagnostic and Therapeutic Approach. Arch Intern Med
158: 1743-1752
[Abstract][Full Text]
Sverrisdóttir, Y. B., Elam, M., Herlitz, H., Bengtsson, B.-A., Johannsson, G.
(1998). Intense Sympathetic Nerve Activity in Adults with Hypopituitarism and Untreated Growth Hormone Deficiency. J. Clin. Endocrinol. Metab.
83: 1881-1885
[Abstract][Full Text]
Toto, R., Shultz, P., Raij, L., Mitchell, H., Shaw, W., Ramjit, D., Toh, J., Shahinfar, S.
(1998). Efficacy and Tolerability of Losartan in Hypertensive Patients With Renal Impairment. Hypertension
31: 684-691
[Abstract][Full Text]
Potter, G. S., Johnson, R. J., Fink, G. D.
(1997). Role of Endothelin in Hypertension of Experimental Chronic Renal Failure. Hypertension
30: 1578-1584
[Abstract][Full Text]
Sander, M., Hansen, J., Victor, R. G.
(1997). The Sympathetic Nervous System Is Involved in the Maintenance but Not Initiation of the Hypertension Induced by N{omega}-Nitro-L-Arginine Methyl Ester. Hypertension
30: 64-70
[Abstract][Full Text]
Kong, T. Q. Jr, Goldberger, J. J., Parker, M., Wang, T., Kadish, A. H.
(1995). Circadian Variation in Human Ventricular Refractoriness. Circulation
92: 1507-1516
[Abstract][Full Text]
Campese, V. M., Kogosov, E.
(1995). Renal Afferent Denervation Prevents Hypertension in Rats With Chronic Renal Failure. Hypertension
25: 878-882
[Abstract][Full Text]
Previous
